CL King Initiates Coverage On Medtronic with Buy Rating, Announces Price Target of $106
Portfolio Pulse from richadhand@benzinga.com
CL King analyst Kristen Stewart has initiated coverage on Medtronic (NYSE:MDT) with a Buy rating and announced a price target of $106.
June 30, 2023 | 12:56 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Medtronic has been given a Buy rating by CL King with a price target of $106.
The Buy rating and price target set by CL King indicates a positive outlook for Medtronic. This could potentially attract investors and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100